UK Probes Popular Diabetes, Weight Loss Drugs for Suicide Risk
- The UK is investigating drugs like Ozempic and Saxenda after reports of suicidal thoughts and self-harm.
- Novo Nordisk's semaglutide and liraglutide are included in the review, along with other GLP-1 receptor agonists.
- The drugs suppress appetite and are gaining popularity for weight loss in the US and Europe.
- Regulators have not established causation between the drugs and adverse reactions.
- The review timeline and conclusions are still unknown as the investigation continues.